drugset / Trial / NCT01478893
Safety and Pharmacodynamics of SEL-068 Vaccine in Smokers and Non-Smokers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and pharmacodynamics of SEL-068. Increasing subcutaneous doses of SEL-068 will be administered to healthy non-smoker and smoker volunteers. The resulting safety profile and anti-nicotine antibody levels will be evaluated.
Timeline
- Start
- 2011-11
- Primary completion
- 2013-01
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SEL-068 | Vaccine | — | Subcutaneous |
Indications
No indication recorded.